Cerebrospinal Fluid Studies in Kenyan Children with Severe Falciparum Malaria.
The pathogenesis of the neurological complications of Plasmodium falciparum malaria is unclear. We measured proteins and amino acids in paired plasma and cerebrospinal fluid (CSF) samples in children with severe falciparum malaria, to assess the integrity of the blood brain barrier (BBB), and look for evidence of intrathecal synthesis of immunoglobulins, excitotoxins and brain damage. METHODS: Proteins of different molecular sizes and immunoglobulins were measured in paired CSF and plasma samples in children with falciparum malaria and either impaired consciousness, prostrate, or seizures. RESULTS: The ratio of CSF to plasma albumin (Q(alb)) exceeded the reference values in 42 (51%) children. The CSF concentrations of the excitotoxic amino acid aspartate and many non-polar amino acids, except alanine, were above the reference value, despite normal plasma concentrations. IgM concentrations were elevated in 21 (46%) and the IgM index was raised in 22 (52%). Identical IgG oligoclonal bands were found in 9 (35%), but only one patient had an increase in the CSF IgG without a concomitant increase in plasma indicating intrathecal synthesis of IgG. CONCLUSIONS: This study indicates that the BBB is mildly impaired in some children with severe falciparum malaria, and this impairment is not confined to cerebral malaria, but also occurs in children with prostrate malaria and to a lesser extent the children with malaria and seizures. There is evidence of intrathecal synthesis of immunoglobulins in children with malaria, but this requires further investigation. This finding, together with raised level of excitotoxic amino acid aspartate could contribute to the pathogenesis of neurological complications in malaria.
Mturi
N
N
Kenya Medical Research Institute, Centre for Geographic Medicine Research (Coast), P. O. Box 230, Kilifi, Kenya.
Keir
G
G
Maclennan
C A
CA
Ross
A
A
Willis
A C
AC
Elford
B C
BC
Berkley
J A
JA
Newton
C R J C
CR
Am J Trop Med Hyg. 1986 Sep;35(5):882-9
2429567
Ann Clin Biochem. 1993 Sep;30 ( Pt 5):454-62
8250497
Ann Neurol. 1998 Jun;43(6):695-702
9629838
Neuropathol Appl Neurobiol. 1999 Aug;25(4):331-40
10476050
Brain. 1990 Oct;113 ( Pt 5):1269-89
2245296
Dan Med Bull. 1993 Sep;40(4):490-2
8222769
Trans R Soc Trop Med Hyg. 2000 Apr;94 Suppl 1:S1-90
11103309
J Infect Dis. 1992 Aug;166(2):350-8
1634806
Am J Pathol. 2002 Feb;160(2):655-66
11839586
Nat Rev Neurosci. 2003 Sep;4(9):752-62
12951567
J Neurol Sci. 1980 Jul;47(1):21-34
6967952
Malar J. 2007 Nov 12;6:147
17997848
Am J Trop Med Hyg. 2000 Feb;62(2):284-90
10813486
Trop Med Int Health. 2005 Mar;10(3):285-92
15730513
Brain Pathol. 1997 Jan;7(1):569-82
9034566
Neuropediatrics. 1982 Feb;13(1):39-41
7078707
J Neurol Sci. 2007 Jul 15;258(1-2):93-8
17459417
Pharmacol Ther. 1998 Jul;79(1):1-53
9719344
J Immunol Methods. 2004 Apr;287(1-2):169-77
15099765
Clin Exp Immunol. 1987 Mar;67(3):524-30
3301098
J Infect Dis. 2002 Mar 1;185(5):650-6
11865422
Clin Chim Acta. 1993 Jul 16;216(1-2):153-66
8222266
Parasitology. 1988 Jun;96 ( Pt 3):579-89
2457201
Arch Neurol. 1978 May;35(5):271-5
348169
J Neurosci Res. 2001 Nov 1;66(3):510-6
11746370
Lancet. 1991 Mar 9;337(8741):573-6
1671941
J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):744-8
11385008
Ann Soc Belg Med Trop. 1986;66(1):23-37
3521502
Acta Paediatr Scand. 1981 Mar;70(2):167-70
7234400
Lancet. 2001 Jun 2;357(9270):1753-7
11403812
Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):386-90
8249058
Am J Trop Med Hyg. 2001 Mar-Apr;64(3-4):207-13
11442219
Ann Clin Biochem. 1990 Sep;27 ( Pt 5):436-43
2281923
Neurology. 2000 Jul 12;55(1):104-11
10891914
J Neurol Neurosurg Psychiatry. 1989 Aug;52(8):949-53
2507746
Clin Chem. 1989 Aug;35(8):1731-4
2474389
N Engl J Med. 1995 May 25;332(21):1399-404
7723795
J Immunol. 1986 Oct 1;137(7):2348-54
3093572
J Immunol Methods. 1997 Jun 23;205(1):35-41
9236913
J Nutr. 2006 Jan;136(1 Suppl):218S-26S
16365086
Acta Neurol Scand. 2005 Nov;112(5):303-8
16218912